Observational studyPharmacological reports : PR2026
Analysis of possible baseline and treatment-course factors associated with non-remission in patients with Crohn's disease treated with ustekinumab: a retrospective real-life analysis.
Antonio Tursi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.